Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Recurrence and Futility After Curative-intent Resection of Pancreatic Ductal Adenocarcinoma

NCT07241676 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Padova as lead sponsor.

NCT NCT07241676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Recurrence and Futility After Curative-intent Resection of Pancreatic Ductal Adenocarcinoma
Lead sponsor
Azienda Ospedaliera di Padova
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 23, 2025
Completion date
September 30, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma (pdac), recurrent pancreatic adenocarcinoma